| Schedule Of Product Sales |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year Ended December 31, |
|
| |
|
2011 |
|
|
2010 |
|
|
2009 |
|
|
Antiviral products: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Atripla |
|
$ |
3,224,518 |
|
|
$ |
2,926,579 |
|
|
$ |
2,382,113 |
|
|
Truvada |
|
|
2,875,141 |
|
|
|
2,649,908 |
|
|
|
2,489,682 |
|
|
Viread |
|
|
737,867 |
|
|
|
732,240 |
|
|
|
667,510 |
|
|
Hepsera |
|
|
144,679 |
|
|
|
200,592 |
|
|
|
271,595 |
|
|
Complera/Eviplera |
|
|
38,747 |
|
|
|
— |
|
|
|
— |
|
|
Emtriva |
|
|
28,764 |
|
|
|
27,679 |
|
|
|
27,974 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total antiviral products |
|
|
7,049,716 |
|
|
|
6,536,998 |
|
|
|
5,838,874 |
|
|
AmBisome |
|
|
330,156 |
|
|
|
305,856 |
|
|
|
298,597 |
|
|
Letairis |
|
|
293,426 |
|
|
|
240,279 |
|
|
|
183,949 |
|
|
Ranexa |
|
|
320,004 |
|
|
|
239,832 |
|
|
|
131,062 |
|
|
Other products |
|
|
109,057 |
|
|
|
66,956 |
|
|
|
16,829 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total product sales |
|
$ |
8,102,359 |
|
|
$ |
7,389,921 |
|
|
$ |
6,469,311 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
| Schedule Of Total Revenues From External Customers And Collaboration Partners By Geographic Region |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year Ended December 31, |
|
| |
|
2011 |
|
|
2010 |
|
|
2009 |
|
|
United States |
|
$ |
4,608,343 |
|
|
$ |
4,224,035 |
|
|
$ |
3,599,313 |
|
|
Outside of the United States: |
|
|
|
|
|
|
|
|
|
|
|
|
|
France |
|
|
587,292 |
|
|
|
519,700 |
|
|
|
468,314 |
|
|
United Kingdom |
|
|
518,377 |
|
|
|
450,368 |
|
|
|
393,036 |
|
|
Spain |
|
|
498,201 |
|
|
|
456,647 |
|
|
|
451,115 |
|
|
Italy |
|
|
392,052 |
|
|
|
345,189 |
|
|
|
323,709 |
|
|
Germany |
|
|
370,403 |
|
|
|
274,991 |
|
|
|
293,111 |
|
|
Switzerland |
|
|
179,582 |
|
|
|
458,606 |
|
|
|
448,203 |
|
|
Other European countries |
|
|
578,792 |
|
|
|
665,237 |
|
|
|
603,068 |
|
|
Other countries |
|
|
652,343 |
|
|
|
554,647 |
|
|
|
431,514 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues outside of the United States |
|
|
3,777,042 |
|
|
|
3,725,385 |
|
|
|
3,412,070 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
8,385,385 |
|
|
$ |
7,949,420 |
|
|
$ |
7,011,383 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |